Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 15;26(10):1786-96.
doi: 10.1091/mbc.E14-10-1474. Epub 2015 Mar 18.

MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε

Affiliations

MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε

Wei Zhao et al. Mol Biol Cell. .

Abstract

MicroRNA-34a (miR-34a) functions to regulate protein expression at the posttranscriptional level by binding the 3' UTR of target genes and regulates functions of vascular endothelial cells. However, the role of miR-34a in regulating blood-tumor barrier (BTB) permeability remains unknown. In this study, we show that miR-34a overexpression leads to significantly increased permeability of BTB, whereas miR-34a silencing reduces the permeability of the BTB. In addition, miR-34a overexpression significantly down-regulates the expression and distribution of tight junction-related proteins in glioma endothelial cells (GECs), paralleled by protein kinase Cε (PKCε) reduction. Moreover, luciferase reporter gene analysis shows that PKCε is the target gene of miR-34a. We also show that cotransfection of miR-34a and PKCε inversely coregulates BTB permeability and protein expression levels of tight junction-related proteins. Pretreatment of ψεRACK, a PKCε-specific activator, decreases BTB permeability in miR-34a-overexpressed GECs and up-regulates expression levels of tight junction proteins. In contrast, pretreatment of εV1-2, a specific PKCε inhibitor, gives opposite results. Collectively, our findings indicate that miR-34a regulates BTB function by targeting PKCε; after phosphorylation, PKCε is activated and contributes to regulation of the expression of tight junction-related proteins, ultimately altering BTB permeability.

PubMed Disclaimer

Figures

FIGURE 1:
FIGURE 1:
Relative expression of miR-34a in ECs and GECs. The expression of miR-34a was detected by quantitative real-time PCR. Relative gene expression was normalized to U6, and analysis was performed by the 2−ΔΔCt method. Data represent means ± SD (n = 6). **p < 0.01 vs. EC group.
FIGURE 2:
FIGURE 2:
The permeability of BTB was altered after overexpression or silencing of miR-34a. (A) Relative expression of miR-34a after transfection with overexpression and silencing plasmids. The endogenous expression of miR-34a was detected by quantitative real-time PCR. The relative gene expression was normalized to U6, and analysis was performed by the 2−ΔΔCt method. Data represent means ± SD (n = 6). (B) TEER values of GECs expressed as Ω⋅cm2. Data represent means ± SD (n = 5). (C) HRP flux was calculated as pmol/cm2. Data represent means ± SD (n = 5). *p < 0.05 and **p < 0.01 vs. miR-34a (+) NC group; #p < 0.05 and ##p < 0.01 vs. miR-34a (–) NC group.
FIGURE 3:
FIGURE 3:
The protein expression of tight junction–related proteins was altered in GECs after overexpression or silencing of miR-34a. (A) Protein expression levels of ZO-1, occludin, and claudin-5 as assessed by Western blot. The relative IDVs of ZO-1, occludin, and claudin-5 are shown using GAPDH as an endogenous control. Values represent the means ± SD (n = 5, each group). **p < 0.01 vs. miR-34a (+) NC group; ##p < 0.01 vs. miR-34a (–) NC group. (B) The distribution and expression of tight junction-related proteins as detected by immunofluorescence assay. ZO-1, occludin, and claudin-5 were respectively labeled with fluorescent secondary antibody, and nuclei (blue) were labeled with DAPI. Scale bars, 20 μm.
FIGURE 4:
FIGURE 4:
The relative expression of PKCε in ECs and GECs. (A) mRNA expression of PKCε as detected by RT-PCR. (B) Protein expression of p-PKCε or PKCε as detected by Western blot assay. GAPDH was used as inner control. Data represent means ± SD (n = 5). **p < 0.01 vs. EC group.
FIGURE 5:
FIGURE 5:
Overexpression or silencing of miR-34a significantly affected the protein expression of p-PKCε and PKCε. (A) PKCε mRNA expression levels as assessed by RT-PCR. IDVs are shown using GAPDH as endogenous control. (B) p-PKCε and PKCε protein levels as assessed by Western blot. (C) Relative IDVs of p-PKCε/GAPDH and PKCε/GAPDH by Western blot. (D) Relative IDV of p-PKCε/PKCε by Western blot. IDVs are shown with GAPDH as endogenous control. Values represent the means ± SD (n = 5). **p < 0.01 vs. miR-34a (+) NC group; ##p < 0.01 vs. miR-34a (–) NC group.
FIGURE 6:
FIGURE 6:
PKCε is a direct target of miR-34a. (A) The putative binding site of PKCε 3′UTR matching with the seed region of miR-34a was predicted with the help of TargetScan. (B) Relative activity of LUC was expressed as firefly/renilla luciferase activity. Values are means ± SD (n = 6). **p < 0.01 vs. PKCε wt + miR-34a (+) NC group.
FIGURE 7:
FIGURE 7:
The permeability of BTB was inversely coregulated by miR-34a and PKCε in GECs. (A) TEER values of GECs were expressed as Ω⋅cm2. (B) HRP flux was calculated as pmol/cm2. Data represent means ± SD (n = 5). *p < 0.05 and **p < 0.01 vs. miR-34a (+) + PKCε (+) group; #p < 0.05 and ##p < 0.01 vs. miR-34a (–) + PKCε (+) group; p < 0.01 vs. miR-34a (+) NC + PKCε (+) NC group; p < 0.05 vs. miR-34a (–) NC + PKCε (–) NC group.
FIGURE 8:
FIGURE 8:
The expression levels of tight junction–related proteins were inversely coregulated by miR-34a and PKCε in GECs. (A, B) Protein expression levels of ZO-1, occludin, and claudin-5 as determined by Western blot. IDVs are shown with GAPDH as endogenous control. Data represent the means ± SD (n = 5). **p < 0.01 vs. miR-34a (+) + PKCε (+) group; ##p < 0.01 vs. miR-34a (–) + PKCε (+) group; p < 0.01 vs. miR-34a (+) NC + PKCε (+) NC group; p < 0.05 vs. miR-34a (–) NC + PKCε (-) NC group.
FIGURE 9.
FIGURE 9.
The permeability of BTB was regulated by PKCε activator ψεRACK and inhibitor εV1-2 peptides (100 nM). (A) TEER values of GECs expressed as Ω⋅cm2. (B) HRP flux calculated as pmol/cm2. Data represent means ± SD (n = 5). p < 0.01 vs. control group; **p < 0.01 vs. miR-34a (+) group; ##p < 0.01 vs. miR-34a (–) group.
FIGURE 10:
FIGURE 10:
The expression of p-PKCε and PKCε, as well as of tight junction–related proteins, in GECs after pretreatment with PKCε activator ψεRACK or inhibitor εV1-2 (100 nM). (A) p-PKCε, PKCε, ZO-1, occludin, and claudin-5 protein levels as assessed by Western blot. (B) Relative IDVs of p-PKCε/GAPDH and PKCε/GAPDH as detected by Western blot. (C) Relative IDV of p-PKCε/PKCε as assessed by Western blot. (D) Relative IDVs of ZO-1 and occludin as determined by Western blot. IDVs are shown with GAPDH as endogenous control. Values represent the means ± SD (n = 5). p < 0.01 vs. control group; *p < 0.05 and **p < 0.01 vs. miR-34a (+) group; ##p < 0.01 vs. miR-34a (–) group.

Similar articles

Cited by

References

    1. Aranha MM, Santos DM, Solá S, Steer CJ, Rodrigues CM. miR-34a regulates mouse neural stem cell differentiation. PLoS One. 2011;6:e21396. - PMC - PubMed
    1. Basu A, Sivaprasad U. Protein kinase Cepsilon makes the life and death decision. Cell Signal. 2007;19:1633–1642. - PMC - PubMed
    1. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84:869–901. - PubMed
    1. Besson A, Wilson TL, Yong VW. The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. J Biol Chem. 2002;277:22073–22084. - PubMed
    1. Brandman R, Disatnik MH, Churchill E, Mochly-Rosen D. Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces. J Biol Chem. 2007;282:4113–4123. - PubMed

Publication types

LinkOut - more resources